Bupropion Morpholinol Impurity (HCl Salt) CAS 106083-71-0
| CAS No. | 106083-71-0 |
| Molecular Formula | C13H18ClNO2 |
| Molecular Weight | N/A |
| Category | Pharmacopoeial Impurity Standards / EP Impurities |
| Availability | In Stock |
Chemical Structure
Description
Based on its molecular formula C13H18ClNO2HCl, Bupropion Morpholinol Impurity (HCl Salt) contains a nitrogen-containing heterocyclic scaffold, an amide group, a hydroxyl group, an ether linkage, chlorine substitution; these features give the compound characteristic absorption bands in UV spectroscopy. The molecular weight of 292.20 g/mol is directly relevant to the identification of the molecular ion in mass spectrometry. The aromatic system may exhibit native fluorescence, enabling detection with a fluorescence detector (FLD).
Bupropion Morpholinol Impurity (HCl Salt) (CAS 106083-71-0) is a certified pharmaceutical impurity reference standard with the molecular formula C13H18ClNO2HCl and a molecular weight of 292.20 g/mol.
This reference standard supports related-substances testing and method development in line with ICH Q3A/Q3B guidance on impurity control, and is suitable for system suitability testing and forced-degradation studies.
CATO manufactures Bupropion Morpholinol Impurity (HCl Salt) under ISO 17034:2016 accreditation with dual CNAS and ANAB accreditation. Each batch is characterized by orthogonal methods and supplied with a full Certificate of Analysis (COA), ensuring metrological traceability.
Physical & Chemical Properties
| Molecular Formula | C13H18ClNO2 HCl |
| Molecular Weight | 292.20 g/mol |
| Appearance | Off-white to pale yellow crystalline powder. (slight halide-like odor, low volatility) |
| Purity | >95% |
| Storage | Store at 2-8°C, protect from light, keep tightly closed to prevent evaporation |
| Solubility (reference) | Soluble in chloroform, dichloromethane, ethyl acetate, DMSO |
| Stability | May oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light; Contains ester bond; hydrolyzes under strong alkaline conditions |
| Degree of Unsaturation (DBE) | 4.0 |
| UV Absorption | UV-absorbing |
| Structural Features | Aromatic ring present |
| CAS Registry Year (est.) | 1987 |
| Halogen Content | Cl-containing |
| Nitrogen Atoms | 1 |
Related Bupropion Standards
- Bupropion Impurity 72 (CAS 102141-11-7)
- Bupropion Impurity 71 (CAS 102141-12-8)
- Bupropion Impurity 9 (CAS 103175-61-7)
- Bupropion Hydrochloride USP Related Compound B (CAS 1049718-43-5)
- Bupropion Hydrochloride USP Related Compound A (CAS 1049718-72-0)
- Bupropion impurity 67 (CAS 1049974-40-4)
- Bupropion Impurity 17 (CAS 10557-17-2)
- Bupropion Hydrochloride-D9 (CAS 1189725-26-5)
Recommended Standards
- Brexpiprazole Impurity 92 (CAS CATO-C4X-113192)
- Paliperidone Impurity 87 (CAS CATO-C4X-172487)
- Polaprezinc Impurity 16 (CAS CATO-C4X-182116)
- 3-(2-Chlorophenyl)-N-(3-cyanophenyl)-5-methylisoxazole-4-carboxamide (CAS 519050-46-5)
- (5-fluoro-1H-1,3-benzodiazol-4-yl)methanamine dihydrochloride (CAS 2060053-31-6)
- (5,5-Difluoro-1-methylpiperidin-3-yl)methanol (CAS 2757097-14-4)
- 2-((3-Ethyl-4-oxo-7-(p-tolyl)-3,4-dihydrothieno[3,2-d]pyrimidin-2-yl)thio)-N-(2-fluorophenyl)acetamide (CAS 1040632-36-7)
- 6-Isopropyl-2-(pyridin-2-yl)quinoline-4-carboxylic acid (CAS 897561-16-9)
- N-[3-Fluoro-4-(4-phenylpiperazin-1-yl)phenyl]-2-(phenylsulfanyl)acetamide (CAS 478260-48-9)
- Pancreatic Polypeptide (1-17)-(Ala31,Aib32)-Neuropeptide Y (18-36) (human) trifluoroacetate salt (CAS 313988-70-4)
Why CATO?
- ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
- 130,000+ catalog items in stock, COA supplied with every batch
- Worldwide shipping with full export documentation (HS code guidance available)
- Technical support: +86 18665070610 / Nicole.chen@cato-chem.com